Form EFFECT Biodexa Pharmaceuticals
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 30, 2026 |
| Accession Number: | 0001214659-26-003931 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northern Trust Expands Relationship with First Sentier Group to Support Singapore Unit Trust Offering
- Rejuuv Medi Spa Announces Continued Leadership in Aesthetic Medicine as Dr. Shawn Seit Receives Industry Recognition for Innovation and Education
- Outlook Therapeutics Announces Pricing of $55.0 Million Public Offering of Common Stock and Warrants
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
